Rx drug information, pharmaceutical research, clinical trials, news, and more
Zolpimist contains zolpidem tartrate, a non-benzodiazepine hypnotic of the imidazopyridine class.
Zolpimist (zolpidem tartrate) Oral Spray is indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation.
Efficacy and safety of a polyherbal sedative-hypnotic formulation NSF-3 in
primary insomnia in comparison to zolpidem: a randomized controlled trial. insomnia... CONCLUSIONS: NSF-3 is a safe and effective short-term alternative to zolpidem for
Novel sublingual low-dose zolpidem tablet reduces latency to sleep onset
following spontaneous middle-of-the-night awakening in insomnia in a randomized,
double-blind, placebo-controlled, outpatient study. to sleep after MOTN awakenings... CONCLUSIONS: 3.5 mg ZST used as needed significantly reduced latency to return to
Comparing effects of clonazepam and zolpidem on sleep quality of patients on
maintenance hemodialysis. patients... CONCLUSIONS: Clonazepam was more effective than zolpidem in the improvement of
A double-blind, randomized, comparative study to evaluate the efficacy and safety
of zaleplon versus zolpidem in shortening sleep latency in primary insomnia. effectiveness and safety of non-BZ zaleplon and zolpidem in primary insomnia... CONCLUSION: There was no significant difference between zaleplon and zolpidem in
Incidence of clinically significant responses to zolpidem among patients with
disorders of consciousness: a preliminary placebo controlled trial. responders... CONCLUSION: These results confirm that clinically significant responses to
All Rights reserved - Copyright DrugLib.com, 2006-2017